Bipore Inc. FDA Inspection Record
Bipore Inc. is an FDA-inspected facility (FEI 1000208907) located in Norwood, NJ, US. RegDataLab tracks 7 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Mar 9, 2017: Voluntary Action Indicated (VAI)
- Inspections on record
- 7 (4 VAI, 3 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 9, 2017 | Voluntary Action Indicated (VAI) | Following/documenting laboratory controls (21 CFR 211.160(a)) Sampling and testing plans not described (21 CFR 211.165(c)) |
| Aug 13, 2015 | Voluntary Action Indicated (VAI) | Procedures not in writing, fully followed (21 CFR 211.22(d)) Training--operations, GMPs, written procedures (21 CFR 211.25(a)) SOPs not followed / documented (21 CFR 211.100(b)) Reports of Analysis (Components) (21 CFR 211.84(d)(2)) and 1 more |
| Jul 9, 2015 | Voluntary Action Indicated (VAI) | No citations listed |
| Nov 19, 2012 | No Action Indicated (NAI) | Written procedures not established/followed (21 CFR 211.67(b)) Establishment of time limitations (21 CFR 211.111) Expiration date lacking (21 CFR 211.137(a)) Prepared for each batch, include complete information (21 CFR 211.188) |
| Mar 18, 2011 | No Action Indicated (NAI) | No citations listed |
| Sep 24, 2010 | Voluntary Action Indicated (VAI) | Equipment Design, Size and Location (21 CFR 211.63) Establishment of time limitations (21 CFR 211.111) Written program not followed (21 CFR 211.166(a)) Sample size - test intervals (21 CFR 211.166(a)(1)) and 1 more |
| Mar 6, 2009 | No Action Indicated (NAI) | No citations listed |
FDA record score
2 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
4 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Mar 9, 2017 | 6 x 0.25 | 1.5 |
| Inspection classified VAI | Aug 13, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Jul 9, 2015 | 10 years or older, so it adds no points | 0 |
| Inspection classified VAI | Sep 24, 2010 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Bipore Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Bipore Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Bipore Inc.
- Location
- Norwood, NJ (US)
- Source
- inspections